Updated August 30 at 6:27am
Life Sciences
89 results total, viewing 11 - 20
Xinyuan “Shawn” Chen, assistant professor of biomedical and pharmaceutical sciences at the University of Rhode Island’s College of Pharmacy, is developing a nicotine vaccine to block the drug’s entry into a smoker’s brain. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
Dr. Barrett Bready is founder and CEO of Nabsys, a genomics firm. An adjunct professor at Brown University where he teaches biotechnology management, Bready also serves as a commissioner on the I-195 Redevelopment District Commission. Bready talked with Providence Business News about Nabsys’ evolution and goals for the future. more
Tech Collective is looking for volunteers for GRRL Tech 2016 to assist with workshops and chaperone. Those who work in STEM – science, technology, engineering and math – fields are welcome to apply. more
(Updated, 6:15 p.m.) Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC. more
Could Providence be the next Cambridge, a city known as a biotechnology hub? Given recent economic-development activity, it would seem that this corner of the technology sector is on the verge of a takeoff. Since CV Properties LLC and … more
Brown University epidemiologist professor discusses the findings of a study on low-income children with mental disorders. more
An independent analysis of promising economic clusters for Providence to nurture has identified five stars: life sciences, food processing and packaging, social enterprise, design coupled with advanced manufacturing, and education technology. more
Life sciences company CytoSolv Inc. has been acquired by Semma Therapeutics of Cambridge, Mass., according to a Slater Technology Fund press release. more
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 9 | Next »